Cargando…

Association of metformin, sulfonylurea and insulin use with brain structure and function and risk of dementia and Alzheimer’s disease: Pooled analysis from 5 cohorts

OBJECTIVE: To determine whether classes of diabetes medications are associated with cognitive health and dementia risk, above and beyond their glycemic control properties. RESEARCH DESIGN AND METHODS: Findings were pooled from 5 population-based cohorts: the Framingham Heart Study, the Rotterdam Stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weinstein, Galit, Davis-Plourde, Kendra L., Conner, Sarah, Himali, Jayandra J., Beiser, Alexa S., Lee, Anne, Rawlings, Andreea M., Sedaghat, Sanaz, Ding, Jie, Moshier, Erin, van Duijn, Cornelia M., Beeri, Michal S., Selvin, Elizabeth, Ikram, M. Arfan, Launer, Lenore J., Haan, Mary N., Seshadri, Sudha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377188/ https://www.ncbi.nlm.nih.gov/pubmed/30768625 http://dx.doi.org/10.1371/journal.pone.0212293

Ejemplares similares

Self-Reported Physical Activity and Relations to Growth and Neurotrophic Factors in Diabetes Mellitus: The Framingham Offspring Study
por: Spartano, Nicole L., et al.
Publicado: (2019)

Overweight, Obesity, and Survival After Stroke in the Framingham Heart Study
por: Aparicio, Hugo J., et al.
Publicado: (2017)

Associations between social relationship measures, serum brain-derived neurotrophic factor, and risk of stroke and dementia
por: Salinas, Joel, et al.
Publicado: (2017)

Association of Accelerometer-Measured Light-Intensity Physical Activity With Brain Volume: The Framingham Heart Study
por: Spartano, Nicole L., et al.
Publicado: (2019)

Relation of plasma β‐amyloid, clusterin, and tau with cerebral microbleeds: Framingham Heart Study
por: Romero, José Rafael, et al.
Publicado: (2020)

Comparative effect of metformin versus sulfonylureas with dementia and Parkinson’s disease risk in US patients over 50 with type 2 diabetes mellitus
por: Newby, Danielle, et al.
Publicado: (2022)

Accelerometer-determined physical activity and cognitive function in middle-aged and older adults from two generations of the Framingham Heart Study
por: Spartano, Nicole L., et al.
Publicado: (2019)

Bone Mineral Density Measurements and Association With Brain Structure and Cognitive Function: The Framingham Offspring Cohort
por: Stefanidou, Maria, et al.
Publicado: (2021)

Relations of Metabolic Health and Obesity to Brain Aging in Young to Middle‐Aged Adults
por: Angoff, Rebecca, et al.
Publicado: (2022)

Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study
por: McGrath, Emer R., et al.
Publicado: (2019)

Circulating IGFBP‐2: a novel biomarker for incident dementia
por: McGrath, Emer R., et al.
Publicado: (2019)

Secular Trends in Head Size and Cerebral Volumes In the Framingham Heart Study for Birth Years 1902–1985
por: DeCarli, Charles, et al.
Publicado: (2023)

The progression of carotid atherosclerosis and imaging markers of dementia
por: Baradaran, Hediyeh, et al.
Publicado: (2020)

Mid‐life and late‐life vascular risk factor burden and neuropathology in old age
por: Conner, Sarah C., et al.
Publicado: (2019)

Association of Metabolic Dysregulation With Volumetric Brain Magnetic Resonance Imaging and Cognitive Markers of Subclinical Brain Aging in Middle-Aged Adults: The Framingham Offspring Study
por: Tan, Zaldy S., et al.
Publicado: (2011)

Growth Differentiation Factor 15 and NT‐proBNP as Blood‐Based Markers of Vascular Brain Injury and Dementia
por: McGrath, Emer R., et al.
Publicado: (2020)

Plasma clusterin levels and risk of dementia, Alzheimer's disease, and stroke
por: Weinstein, Galit, et al.
Publicado: (2016)

The genetics of circulating BDNF: towards understanding the role of BDNF in brain structure and function in middle and old ages
por: Li, Shuo, et al.
Publicado: (2020)

Identifying Blood Biomarkers for Dementia Using Machine Learning Methods in the Framingham Heart Study
por: Lin, Honghuang, et al.
Publicado: (2022)

Inter‐Relations of Orthostatic Blood Pressure Change, Aortic Stiffness, and Brain Structure and Function in Young Adults
por: Cooper, Leroy L., et al.
Publicado: (2017)

Circulating biomarkers that predict incident dementia
por: Weinstein, Galit, et al.
Publicado: (2014)

Aging, prevalence and risk factors of MRI-visible enlarged perivascular spaces
por: Lara, Frances Rodriguez, et al.
Publicado: (2022)

Heritability and genome-wide associations studies of cerebral blood flow in the general population
por: Ikram, M Arfan, et al.
Publicado: (2017)

Sulfonylureas: Asset or liability?
por: Lakhani, Om J., et al.
Publicado: (2015)

Sulfonylureas at the Glomerular Battlefield
por: Kalra, Sanjay, et al.
Publicado: (2018)

Telomere Length and the Risk of Alzheimer’s Disease: The Rotterdam Study
por: Fani, Lana, et al.
Publicado: (2020)

Whole blood microRNA expression associated with stroke: Results from the Framingham Heart Study
por: Salinas, Joel, et al.
Publicado: (2019)

Sulfonylurea and neuroprotection: The bright side of the moon
por: Hussien, Nawar R., et al.
Publicado: (2018)

Sulfonylurea action re‐revisited
por: Seino, Susumu, et al.
Publicado: (2010)

Sulfonylureas and their use in clinical practice
por: Sola, Daniele, et al.
Publicado: (2015)

No Racial Differences in the Association of Glycated Hemoglobin With Kidney Disease and Cardiovascular Outcomes
por: Selvin, Elizabeth, et al.
Publicado: (2013)

Circulating ceramide ratios and risk of vascular brain aging and dementia
por: McGrath, Emer R., et al.
Publicado: (2020)

Trends in the incidence of dementia: design and methods in the Alzheimer Cohorts Consortium
por: Chibnik, Lori B., et al.
Publicado: (2017)

Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus – International Task Force
por: Kalra, Sanjay, et al.
Publicado: (2018)

The prevalence, correlation, and co-occurrence of neuropathology in old age: harmonisation of 12 measures across six community-based autopsy studies of dementia
por: Nichols, Emma, et al.
Publicado: (2023)

Pioglitazone and sulfonylureas: effectively treating type 2 diabetes
por: Hanefeld, M
Publicado: (2007)

APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts
por: Qian, Jing, et al.
Publicado: (2017)

Increases in Biomarkers of Hyperglycemia With Age in the Atherosclerosis Risk in Communities (ARIC) Study
por: Warren, Bethany, et al.
Publicado: (2017)

Sulfonylureas: Assets in the past, present and future
por: Kalra, Sanjay, et al.
Publicado: (2015)

Sulfonylureas: Scoring beyond START STUDY
por: Shaikh, Altamash
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fmhar8st0gaja4c7lq0sj4970n